Automated cell counters provide efficient and accurate cell counting in biology and medical research labs. These counters help analyze blood parameters like hematocrit, hemoglobin and red blood cell counts. They facilitate fast cell counting of lymphocytes, monocytes and granulocytes to diagnose diseases.
The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing demand for high accuracy cell counting from research institutes and pharmaceutical companies is a major factor driving the growth of the automated cell counters market. Automated cell counters provide lab-grade consistency and accuracy for cell counting applications. They eliminate human error and provide reproducible results. With built-in intelligence and analytical software, automated cell counters help researchers obtain reliable cellular data for diagnosis and drug development processes. This factor is expected to propel the demand for automated cell counters over the forecast period.
SWOT Analysis
Strength: Automated cell counters offer accurate and reproducible results along with high-throughput capabilities. They reduce manual errors and ensure consistent performance.
Weakness: High initial costs associated with automated cell counters limit their adoption in small labs and research facilities. Technical issues and maintenance needs also increase long-term operational expenses.
Opportunity: Rising research activities in pharmaceutical and biotechnology sectors boost the demand for automated cell counting solutions. Growing stem cell therapy and cancer diagnosis present opportunities.
Threats: Limitations of current technologies in terms of accuracy for complex and multinuclear cells pose challenges. Open-source image analysis tools threaten commercial automated cell counters.
Key Takeaways
The global automated cell counters market is expected to witness high growth. The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.
The North American region currently dominates the automated cell counters market due to presence of major players and availability of funding for research. The Asia Pacific region is expected to grow at the fastest pace during the forecast period owing to increasing R&D expenditure, stem cell research, and growing biopharmaceutical industry.
Key players related content comprises Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan. These players are focusing on new product launches and mergers & acquisitions to strengthen their market position. For instance, in 2022, Thermo Fisher Scientific launched Novocyte 10000 cell counter for research and clinical applications.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
